These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19170317)

  • 1. The quadrivalent human papillomavirus vaccine.
    Wheat A
    Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S;
    Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract]   [Full Text] [Related]  

  • 3. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):65-6. PubMed ID: 16977280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK; Alkhateeb FM
    Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
    Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E
    Vaccine; 2008 Dec; 26(52):6844-51. PubMed ID: 18930097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL.
    Reinis M
    Curr Opin Mol Ther; 2004 Apr; 6(2):206-11. PubMed ID: 15195933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against HPV in adults].
    Gil Á
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
    [No Abstract]   [Full Text] [Related]  

  • 10. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P; Cherry JD
    Pediatr Res; 2007 Nov; 62(5):527. PubMed ID: 18049369
    [No Abstract]   [Full Text] [Related]  

  • 11. Cervarix--a second HPV vaccine.
    Med Lett Drugs Ther; 2010 May; 52(1338):37-8. PubMed ID: 20467355
    [No Abstract]   [Full Text] [Related]  

  • 12. CDC panel backs routine HPV vaccination.
    Kuehn BM
    JAMA; 2006 Aug; 296(6):640-1. PubMed ID: 16896097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
    Six L; Joura EA
    Wien Med Wochenschr; 2007; 157(5-6):130-2. PubMed ID: 17427010
    [No Abstract]   [Full Text] [Related]  

  • 14. Gardasil: Introducing the new human papillomavirus vaccine.
    McLemore MR
    Clin J Oncol Nurs; 2006 Oct; 10(5):559-60. PubMed ID: 17063609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P; Jit M
    Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of general human papillomavirus vaccination in sexually active women].
    Hampl M
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S95-9. PubMed ID: 19353480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statement on human papillomavirus vaccine. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Feb; 33(ACS-2):1-31. PubMed ID: 17520773
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus typing in reporting of condyloma.
    Sturegård E; Johansson H; Ekström J; Hansson BG; Johnsson A; Gustafsson E; Dillner J; Forslund O
    Sex Transm Dis; 2013 Feb; 40(2):123-9. PubMed ID: 23324975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
    Garland SM; Steben M; Sings HL; James M; Lu S; Railkar R; Barr E; Haupt RM; Joura EA
    J Infect Dis; 2009 Mar; 199(6):805-14. PubMed ID: 19199546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.